Revealing Rett: Disease-Based Treatments to Improve Outcomes (CME/CE Webcast)
Activity Description and Purpose
In this educational activity, learners will become proficient at recognizing the subtle signs and symptoms of Rett syndrome (RTT) during the early stages of the disorder, along with the features that should prompt a referral in patients exhibiting potential signs of RTT. Guidelines for general practitioners who may treat patients with RTT and guidance on multidisciplinary management will be reviewed. In addition, clinical data on approved and emerging agents to treat this debilitating disorder will be discussed. The desired results of this activity are for general pediatricians and NPs and PAs in the pediatric care setting to improve their knowledge of RTT and emerging/new medications to enhance care of their patients with RTT.
This educational activity is intended for general pediatricians, nurse practitioners, and physician assistants.
After completing this activity, participants will be better able to:
- Recognize subtle signs and symptoms of Rett syndrome during the early stages of the disorder
- Distinguish features that should prompt a referral in patients exhibiting potential signs of Rett syndrome
- Identify guidelines used for patients with Rett syndrome
- Apply guideline-based multidisciplinary care to individualize care of patients with Rett syndrome
- Identify recent clinical trial data of emerging/new disorder-specific therapies for Rett syndrome
|Arthur Beisang, MD
Complex Care Pediatrician
St Paul, Minnesota
Constance L. Smith-Hicks, MD, PhD
MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.
Arthur Beisang, MD, is an advisory board member of ACADIA Pharmaceuticals Inc.
Constance L. Smith-Hicks, MD, PhD, is a consultant for ACADIA Pharmaceuticals Inc, PaxMedica, Inc, and Stoke Therapeutics.
This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.
Planners, Managers, and Writers
Carrie Allen, PharmD, BCPP, BCPS, MedEdicus Content Manager for this activity, was previously employed by CVS within the past 2 years, but that relationship has ended.
Other MedEdicus planners, managers, and writers have no relevant commercial relationships to disclose.
Learners must take the pretest, view the webcast, and complete a posttest and evaluation form to receive a certificate of completion. Your chosen session must be viewed in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
ACCME Accreditation Statement
MedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
MedEdicus LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Interprofessional Joint Accreditation Statement
In support of improving patient care, Amedco is jointly accredited by the ACCME, the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.
Disclosure of Commercial Support
This continuing medical education activity is supported through an educational grant from ACADIA Pharmaceuticals Inc.
This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.
Provider Contact Information
For questions about this educational activity, please contact MedEdicus LLC at email@example.com.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Amedco, MedEdicus LLC, or ACADIA Pharmaceuticals Inc.
This CME/CE activity is copyrighted to MedEdicus LLC ©2023. All rights reserved. 301
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation